Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 4/20 | 0.67 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.48 |
| ▸ | LSS | P48449 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrabuthylammonium SCHEMBL560748 | 1.00 | SLC22A1 (0.67) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL313065 | 1.00 | SLC22A1 (0.67) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| SCHEMBL10589857 | 0.95 | SLC22A1 (0.65) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrahexylammonium SCHEMBL4303466 | 0.92 | SLC22A1 (0.68) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrahexylammonium SCHEMBL14250018 | 0.92 | SLC22A1 (0.68) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL4934836 | 0.88 | SLC22A1 (0.75) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL3906566 | 0.88 | SLC22A1 (0.75) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL16973025 | 0.88 | SLC22A1 (0.75) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL7558637 | 0.87 | SLC22A1 (0.57) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL7970991 | 0.86 | SLC22A1 (0.71) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240120519-A1 | NON-AQUEOUS REDOX FLOW BATTERIES | ENI S.P.A. (IT) | 2024-04-11 | — | — | US | disclosed |
| EP-4252297-A1 | NON-AQUEOUS REDOX FLOW BATTERIES | ENI S.p.A. (IT) | 2023-10-04 | — | — | EP | disclosed |
| WO-2022112932-A1 | NON-AQUEOUS REDOX FLOW BATTERIES | ENI S.P.A. (IT) | 2022-06-02 | — | — | WO | disclosed |
| EP-3569624-A1 | METHOD FOR THE PRODUCTION OF POLYISOCYANATES COMPRISING ISOCYANURATE GROUPS AND THEIR USE | BASF SE (DE) | 2019-11-20 | — | — | EP | disclosed |
| US-10428043-B2 | Green oxidation catalytic system | TRUSTEES OF BOSTON UNIVERSITY (US) | 2019-10-01 | — | — | US | disclosed |
| EP-3498743-A1 | METHOD FOR PRODUCING A PREPOLYMER CONTAINING POLYOXYMETHYLENE GROUPS | Covestro Deutschland AG (DE) | 2019-06-19 | — | — | EP | disclosed |
| US-20180297976-A1 | GREEN OXIDATION CATALYTIC SYSTEM | TRUSTEES OF BOSTON UNIVERSITY (US) | 2018-10-18 | — | — | US | disclosed |
| EP-3143185-A1 | METHOD FOR PRODUCING 1.5-DIAMINONAPHTHALENE AND 1-AMINO-5-NITRONAPHTHALENE BY DIRECT ELECTROCHEMICAL AMINATION OF NON-ACTIVATED OR DEACTIVATED AROMATIC SYSTEMS ON BORON-DOPED DIAMOND ANODES | Covestro Deutschland AG (DE) | 2017-03-22 | — | — | EP | disclosed |
| WO-2016100850-A2 | GREEN OXIDATION CATALYTIC SYSTEM | TRUSTEES OF BOSTON UNIVERSITY (US) | 2016-06-23 | — | — | WO | disclosed |
| WO-2015173221-A1 | METHOD FOR PRODUCING 1.5-DIAMINONAPHTHALENE AND 1-AMINO-5-NITRONAPHTHALENE BY DIRECT ELECTROCHEMICAL AMINATION OF NON-ACTIVATED OR DEACTIVATED AROMATIC SYSTEMS ON BORON-DOPED DIAMOND ANODES | COVESTRO DEUTSCHLAND AG (DE) | 2015-11-19 | — | — | WO | disclosed |
| EP-0290385-B1 | PROCESS FOR PREPARING 4-ACYLOXY-3-HYDROXYETHYL-AZETIDINONES | CIBA-GEIGY AG (CH) | 1992-10-21 | — | — | EP | disclosed |
| EP-0382106-A2 | Process for manufacturing thiophene derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-08-16 | — | — | EP | disclosed |
| EP-0380767-A2 | Process for the adherent metallisation of highly temperature-stable plastics | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-08-08 | — | — | EP | disclosed |
| EP-0379062-A2 | Acicular magnetic iron pigments with an adjustable coercive force, and process for their production; Fe metal pigments for magnetic recording with an adjustable coercive force | Studiengesellschaft Kohle mbH (DE) | 1990-07-25 | — | — | EP | disclosed |
| EP-0317748-A2 | Pre-treatment process for synthetic resins | SCHERING AKTIENGESELLSCHAFT (DE) | 1989-05-31 | — | — | EP | disclosed |
| EP-0085158-B1 | PROCESS FOR THE PREPARATION OF CYCLOALKENON DERIVATIVES | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1985-06-19 | — | — | EP | disclosed |
| EP-0127216-A1 | Process for the preparation of 21-hydroxy-20-keto-delta16-steroids and intermediate compounds formed in this process | ROUSSEL-UCLAF (FR) | 1984-12-05 | — | — | EP | disclosed |
| EP-0094563-A2 | Process for the production of electrically conductive condensed aromatic compounds, products obtained thereby and their use | BASF Aktiengesellschaft (DE) | 1983-11-23 | — | — | EP | disclosed |
| EP-0089575-A1 | Method of manufacturing conductive oligophenyls, products manufactured by this method and their use | BASF Aktiengesellschaft (DE) | 1983-09-28 | — | — | EP | disclosed |
| EP-0085158-A2 | Process for the preparation of cycloalkenon derivatives | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1983-08-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10428043-B2 | Green oxidation catalytic system | TKT, OGDH, SOD1 | SLC22A1 3772/4885SLC22A2 3643/4885ALDH1A1 780/4885 |
| US-20180297976-A1 | GREEN OXIDATION CATALYTIC SYSTEM | TKT, OGDH, SOD1 | SLC22A1 3772/4885SLC22A2 3643/4885ALDH1A1 780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.